Hideki Tani
Toyama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Genome-Epidemiological and Seroepidemiological Study of the COVID-19 Cluster in a Nursing Home.
Journal: Japanese journal of infectious diseases
Published: November 30, 2025
Detection of neutralizing antibody against SARS-CoV-2 in a patient with X-linked agammaglobulinemia receiving immunoglobulin replacement therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 05, 2025
Successful 30-Day Nirmatrelvir/Ritonavir Treatment of a Patient Who Developed Multi-relapsed COVID-19 After Receiving R-CHOP Against Follicular Lymphoma.
Journal: Cureus
Published: February 14, 2025
Development of neutralization tests using single-round infectious particles and cytopathic effect as an alternative method for measuring antibody titers against Japanese encephalitis virus in national epidemiological surveillance program of vaccine-preventable diseases in Japan.
Journal: Journal of virological methods
Published: November 27, 2024
A transient reduction of the varicella-zoster virus-specific immunoglobulin G level after vaccination against severe acute respiratory syndrome coronavirus 2 with an mRNA vaccine in nursing home residents, but not staff.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: November 18, 2024
Development and clinical evaluation of a MPXV antigen-detecting rapid diagnostic test.
Journal: Journal of virological methods
Published: August 02, 2024
Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: July 17, 2024
Inhibition Mechanism of SARS-CoV-2 Infection by a Cholesterol Derivative, Nat-20(S)-yne.
Journal: Biological & pharmaceutical bulletin
Published: May 01, 2024
COVID-19 mRNA booster vaccination induces robust antibody responses but few adverse events among SARS-CoV-2 naïve nursing home residents.
Journal: Scientific reports
Published: April 09, 2024
Last Updated: 09/26/2026